Biologic therapy targeting IL-17 ameliorates a case of congenital ichthyosiform cornification disorder

J Dtsch Dermatol Ges. 2019 Jan;17(1):70-72. doi: 10.1111/ddg.13716. Epub 2018 Dec 3.

Authors

Daniela Haiges¹, Judith Fischer², Steffen Hörer², Cristina Has¹, Christoph M Schempp¹

Affiliations

¹ Department of Dermatology, Medical Center - Faculty of Medicine, University of Freiburg, Germany.
² Institute of Human Genetics, Medical Center - Faculty of Medicine, University of Freiburg, Germany.

PMID: 30506809
DOI: 10.1111/ddg.13716

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / therapeutic use
Biological Therapy / methods*
Humans
Ichthyosiform Erythroderma, Congenital / drug therapy*
Ichthyosiform Erythroderma, Congenital / metabolism
Ichthyosiform Erythroderma, Congenital / pathology*
Injections, Subcutaneous
Interleukin-17 / antagonists & inhibitors
Interleukin-17 / immunology
Male
Skin / pathology
Skin Neoplasms / pathology
Treatment Outcome
Young Adult

Substances

Antibodies, Monoclonal, Humanized
IL17A protein, human
Interleukin-17
secukinumab